Difference between revisions of "Team:Aix-Marseille/M13 Design"

(Engineering M13)
Line 1: Line 1:
 
{{Aix-Marseille|title=M13 Design|toc=__TOC__}}
 
{{Aix-Marseille|title=M13 Design|toc=__TOC__}}
  
==Engineering M13==
+
==Engineering M13 helper phage==
 
[[File:T--Aix-Marseille--M13K07.png|400px|right]]
 
[[File:T--Aix-Marseille--M13K07.png|400px|right]]
  
[[Team:Aix-Marseille/M13|M13]] is a phage that targets ''E.coli''. Our goal is to create an engineered M13 phage-like particle that will be specific to [[Team:Aix-Marseille/Xylella_fastidiosa|''Xylella fastidiosa'']]. To do so, we look into the attachment protein of [[Team:Aix-Marseille/M13|M13]]. This protein contains three domains (D1, D2 and D3) and a signal sequence. In filamentous phages, only D1 and D2 are crucial for target attachment while the signal sequence is crucial for the excretion of p3 in the periplasm<ref name="Heilpern">Heilpern, A. J. & Waldor, M. K. pIIICTX, a predicted CTXphi minor coat protein, can expand the host range of coliphage fd to include Vibrio cholerae. J. Bacteriol. 185, 1037–1044 (2003).</ref> and D3 is important for phage formation.
+
[[Team:Aix-Marseille/M13|M13]] is a phage that targets ''E.coli''. Our goal is to create an engineered M13 phage-like particle that will be specific to [[Team:Aix-Marseille/Xylella_fastidiosa|''Xylella fastidiosa'']]. To do so, we look into the attachment protein of [[Team:Aix-Marseille/M13|M13]]. This protein contains three domains (D1, D2, and D3) and a signal sequence. In filamentous phages, only D1 and D2 are crucial for target attachment while the signal sequence is crucial for the excretion of p3 in the periplasm<ref name="Heilpern">Heilpern, A. J. & Waldor, M. K. pIIICTX, a predicted CTXphi minor coat protein, can expand the host range of coliphage fd to include Vibrio cholerae. J. Bacteriol. 185, 1037–1044 (2003).</ref> and D3 is important for phage formation.
  
In our design we chose to use M13KO7 from New England BioLab. '''M13KO7''' is an M13 derivative which carries the mutation Met40Ile in gII, with the origin of replication from P15A and the kanamycin resistance gene from Tn903 both inserted within the [[Team:Aix-Marseille/M13|M13]] origin of replication.
+
In our design, we chose to use M13KO7 from New England BioLab. '''M13KO7''' is an M13 derivative which carries the mutation Met40Ile in gII, with the origin of replication from P15A and the kanamycin resistance gene from Tn903 both inserted within the [[Team:Aix-Marseille/M13|M13]] origin of replication.
  
In order to engineer multiple phages to infect various pathogenes, we first decided to remove D1 and D2 and replace them with the D1 and D2 of [[Team:Aix-Marseille/Xylella_fastidiosa|''X. fastidiosa'']]'s filamentous phage<ref>Chen, J. & Civerolo, E. L. Morphological evidence for phages in Xylella fastidiosa. Virology Journal 5, 75 (2008).</ref>. Thus we designed the biobrick with the attachment domains for ''E.coli'' [http://parts.igem.org/Part:BBa_K2255008 BBa_K2255008] and [[Team:Aix-Marseille/Xylella_fastidiosa|''X. fastidiosa'']] [http://parts.igem.org/Part:BBa_K2255018 BBa_K2255018]. In our design we initially wanted to keep the signal sequence and D3 of M13, because their are crucial for the formation of the phage.  
+
In order to engineer multiple phages to infect various pathogens, we first decided to remove D1 and D2 and replace them with the D1 and D2 of [[Team:Aix-Marseille/Xylella_fastidiosa|''X. fastidiosa'']]'s filamentous phage<ref>Chen, J. & Civerolo, E. L. Morphological evidence for phages in Xylella fastidiosa. Virology Journal 5, 75 (2008).</ref>. Thus we designed the biobrick with the attachment domains for ''E.coli'' [http://parts.igem.org/Part:BBa_K2255008 BBa_K2255008] and [[Team:Aix-Marseille/Xylella_fastidiosa|''X. fastidiosa'']] [http://parts.igem.org/Part:BBa_K2255018 BBa_K2255018]. In our design we initially wanted to keep the signal sequence and D3 of M13, because their are crucial for the formation of the phage.  
  
 
[[File:T--Aix-Marseille--P3map.png|1000px|center]]
 
[[File:T--Aix-Marseille--P3map.png|1000px|center]]
  
To enable the D1-D2 switch, we inserted two restriction sites (AvrII and BspI) in the p3 gene which are compatible with XbaI and AgeI. With this modification we could remove D1 and D2 from the p3 gene, but we also removed the signal sequence. As we removed it with our construction, we had to put another one. We therefore designed [http://parts.igem.org/Part:BBa_K2255007 BBa_K2255007].
+
To enable the D1-D2 switch, we inserted two restriction sites (AvrII and BspI) in the p3 gene which are compatible with XbaI and AgeI. With this modification, we could remove D1 and D2 from the p3 gene, but we also removed the signal sequence. As we removed it with our construction, we had to put another one. We therefore designed [http://parts.igem.org/Part:BBa_K2255007 BBa_K2255007].
  
 
Another way to engineer [[Team:Aix-Marseille/M13|M13]] is to entirely remove the protein III from the phage genome and to reconstruct it in another plasmid. Using this method, we created another part, [http://parts.igem.org/Part:BBa_K2255005 BBa_K2255005], which is the domain involved in the assembly and release of M13 particles.
 
Another way to engineer [[Team:Aix-Marseille/M13|M13]] is to entirely remove the protein III from the phage genome and to reconstruct it in another plasmid. Using this method, we created another part, [http://parts.igem.org/Part:BBa_K2255005 BBa_K2255005], which is the domain involved in the assembly and release of M13 particles.
Line 18: Line 18:
 
==Phagemid==
 
==Phagemid==
  
As the M13KO7 genome is not able to initiate the phage assembly, we used a phagemid that carries a toxin to assemble our ingeneered M13 phage.  
+
As the M13KO7 genome is only poorly assembled into phage, we decided to use a phagemid to carry a toxin gene and be assembled into our engineered phage like particles.  
  
 
We first thought about using the [http://parts.igem.org/Part:BBa_K1491017 Super Nova toxin], made by the iGEM team Carnegie Mellon in 2014. This toxin has multiple benefits: because of the production of ROS occuring only in a yellow - orange light, we could produce phages-like particules carring this toxin without killing ''E.coli''. However, when this toxin would be produced in [[Team:Aix-Marseille/Xylella_fastidiosa|''X. fastidiosa'']] with the light coming from the sun, the bacterium will be harmed, even if it is in the Xylem vessels.
 
We first thought about using the [http://parts.igem.org/Part:BBa_K1491017 Super Nova toxin], made by the iGEM team Carnegie Mellon in 2014. This toxin has multiple benefits: because of the production of ROS occuring only in a yellow - orange light, we could produce phages-like particules carring this toxin without killing ''E.coli''. However, when this toxin would be produced in [[Team:Aix-Marseille/Xylella_fastidiosa|''X. fastidiosa'']] with the light coming from the sun, the bacterium will be harmed, even if it is in the Xylem vessels.

Revision as of 21:24, 5 October 2017

M13 Design

Engineering M13 helper phage

T--Aix-Marseille--M13K07.png

M13 is a phage that targets E.coli. Our goal is to create an engineered M13 phage-like particle that will be specific to Xylella fastidiosa. To do so, we look into the attachment protein of M13. This protein contains three domains (D1, D2, and D3) and a signal sequence. In filamentous phages, only D1 and D2 are crucial for target attachment while the signal sequence is crucial for the excretion of p3 in the periplasm[1] and D3 is important for phage formation.

In our design, we chose to use M13KO7 from New England BioLab. M13KO7 is an M13 derivative which carries the mutation Met40Ile in gII, with the origin of replication from P15A and the kanamycin resistance gene from Tn903 both inserted within the M13 origin of replication.

In order to engineer multiple phages to infect various pathogens, we first decided to remove D1 and D2 and replace them with the D1 and D2 of X. fastidiosa's filamentous phage[2]. Thus we designed the biobrick with the attachment domains for E.coli [http://parts.igem.org/Part:BBa_K2255008 BBa_K2255008] and X. fastidiosa [http://parts.igem.org/Part:BBa_K2255018 BBa_K2255018]. In our design we initially wanted to keep the signal sequence and D3 of M13, because their are crucial for the formation of the phage.

T--Aix-Marseille--P3map.png

To enable the D1-D2 switch, we inserted two restriction sites (AvrII and BspI) in the p3 gene which are compatible with XbaI and AgeI. With this modification, we could remove D1 and D2 from the p3 gene, but we also removed the signal sequence. As we removed it with our construction, we had to put another one. We therefore designed [http://parts.igem.org/Part:BBa_K2255007 BBa_K2255007].

Another way to engineer M13 is to entirely remove the protein III from the phage genome and to reconstruct it in another plasmid. Using this method, we created another part, [http://parts.igem.org/Part:BBa_K2255005 BBa_K2255005], which is the domain involved in the assembly and release of M13 particles.

Phagemid

As the M13KO7 genome is only poorly assembled into phage, we decided to use a phagemid to carry a toxin gene and be assembled into our engineered phage like particles.

We first thought about using the [http://parts.igem.org/Part:BBa_K1491017 Super Nova toxin], made by the iGEM team Carnegie Mellon in 2014. This toxin has multiple benefits: because of the production of ROS occuring only in a yellow - orange light, we could produce phages-like particules carring this toxin without killing E.coli. However, when this toxin would be produced in X. fastidiosa with the light coming from the sun, the bacterium will be harmed, even if it is in the Xylem vessels. To optimize the production of this toxin in X. fastidiosa we tried to find a strong and constitutive promoter in this bacterium.

To deliver our toxin, we either created a phagemid that contains the [http://parts.igem.org/Part:BBa_K1445000 M13 origin] (oriM13) which gives it the opportunity to be used in the phage construction, or we used the phagemid pBluescript II KS(+). Both of those phagemid contain a M13 origin of replication and a gene for antibiotic resistance. We inserted it in both, [http://parts.igem.org/Part:BBa_K608002 E.coli promoter] or [http://parts.igem.org/Part:BBa_K2255004 X. fastidiosa promoter] along with the SuperNova gene.

T--Aix-Marseille--pbluescript-SN.jpeg
T--Aix-Marseille--pSB1C3-SN.jpeg

References

  1. Heilpern, A. J. & Waldor, M. K. pIIICTX, a predicted CTXphi minor coat protein, can expand the host range of coliphage fd to include Vibrio cholerae. J. Bacteriol. 185, 1037–1044 (2003).
  2. Chen, J. & Civerolo, E. L. Morphological evidence for phages in Xylella fastidiosa. Virology Journal 5, 75 (2008).